Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gonçalves AC"" wg kryterium: Autor


Tytuł:
In Vitro Characterization of Reversine-Treated Gingival Fibroblasts and Their Safety Evaluation after In Vivo Transplantation.
Autorzy:
Marto CM; Institute of Experimental Pathology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Institute of Integrated Clinical Practice and Laboratory of Evidence-Based and Precision Dentistry, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Laranjo M; Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Gonçalves AC; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Paula A; Institute of Integrated Clinical Practice and Laboratory of Evidence-Based and Precision Dentistry, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Jorge J; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Caetano-Oliveira R; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Pathology Department, Centro Hospitalar e Universitário de Coimbra, 3000-075 Coimbra, Portugal.; Germano de Sousa-Centro de Diagnóstico Histopatológico CEDAP, University of Coimbra, 3000-377 Coimbra, Portugal.
Sousa MI; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal.; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3000-548 Coimbra, Portugal.
Oliveiros B; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Laboratory of Biostatistics and Medical Informatics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Ramalho-Santos J; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Department of Life Sciences, University of Coimbra, 3000-456 Coimbra, Portugal.; CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3000-548 Coimbra, Portugal.
Sarmento-Ribeiro AB; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH) and University Clinic of Hematology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Marques-Ferreira M; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Institute of Endodontics, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal.
Cabrita A; Institute of Experimental Pathology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Botelho MF; Institute of Biophysics, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Carrilho E; Institute of Integrated Clinical Practice and Laboratory of Evidence-Based and Precision Dentistry, Faculty of Medicine, University of Coimbra, 3000-075 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Centre for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2024 Jan 31; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 31.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Anti-Algics in the Therapeutic Response of Breast and Urological Cancers.
Autorzy:
Matos AC; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.
Lorigo J; Department of Urology and Renal Transplantation, Centro Hospitalar e Universitário de Coimbra (CHUC), 3004-561 Coimbra, Portugal.
Marques IA; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.
Abrantes AM; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Jóia-Gomes M; Department of Mathematics, University of Aveiro, 3810-193 Aveiro, Portugal.
Sa-Couto P; Center for Research & Development in Mathematics and Applications (CIDMA), Department of Mathematics, University of Aveiro, 3810-193 Aveiro, Portugal.
Gonçalves AC; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Laboratory of Oncobiology and Hematology and University Clinics of Hematology and Oncology, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.
Valentim A; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.; Anaesthesiology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3004-561 Coimbra, Portugal.
Tavares-Silva E; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Department of Urology and Renal Transplantation, Centro Hospitalar e Universitário de Coimbra (CHUC), 3004-561 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Figueiredo A; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Department of Urology and Renal Transplantation, Centro Hospitalar e Universitário de Coimbra (CHUC), 3004-561 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Pires AS; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Botelho MF; Coimbra Institute for Clinical and Biomedical Research (iCBR), Area of Environment, Genetics and Oncobiology (CIMAGO), Biophysics Institute, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3004-561 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Dec 29; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 29.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Opioid-Related Disorders*
Prostatic Neoplasms*/drug therapy
Urologic Neoplasms*
Humans ; Male ; Analgesics, Opioid ; Anesthetics, Local/pharmacology ; Anesthetics, Local/therapeutic use ; Cross-Sectional Studies ; Prospective Studies ; Female
Czasopismo naukowe
Tytuł:
Diversity of Culture Microorganisms from Portuguese Sweet Cherries.
Autorzy:
Gonçalves AC; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.; CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.
Falcão A; CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.; Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Alves G; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.
Silva LR; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.; CPIRN-UDI/IPG-Centro de Potencial e Inovação em Recursos Naturais, Unidade de Investigação para o Desenvolvimento do Interior do Instituto Politécnico da Guarda, 6300-559 Guarda, Portugal.; Chemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, Pólo II-Pinhal de Marrocos, University of Coimbra, 3030-790 Coimbra, Portugal.
Flores-Félix JD; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-506 Covilhã, Portugal.; Microbiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain.
Pokaż więcej
Źródło:
Life (Basel, Switzerland) [Life (Basel)] 2023 Dec 11; Vol. 13 (12). Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells.
Autorzy:
Lapa BS; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.
Costa MI; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.
Figueiredo D; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Jorge J; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Alves R; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Monteiro AR; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Serambeque B; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Institute of Biophysics, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Laranjo M; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Institute of Biophysics, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Botelho MF; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Institute of Biophysics, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Carreira IM; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Cytogenetics and Genomics Laboratory, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Sarmento-Ribeiro AB; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-061 Coimbra, Portugal.
Gonçalves AC; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Oct 18; Vol. 24 (20). Date of Electronic Publication: 2023 Oct 18.
Typ publikacji:
Journal Article
MeSH Terms:
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/genetics
Tumor Suppressor Protein p53*/genetics
Tumor Suppressor Protein p53*/metabolism
Humans ; Apoptosis ; Cell Cycle ; Cell Cycle Checkpoints ; DNA/metabolism ; DNA Damage ; DNA-Activated Protein Kinase/antagonists & inhibitors ; DNA-Activated Protein Kinase/metabolism
Czasopismo naukowe
Tytuł:
Blackberries and Mulberries: Berries with Significant Health-Promoting Properties.
Autorzy:
Martins MS; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.
Gonçalves AC; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3000-548 Coimbra, Portugal.
Alves G; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.
Silva LR; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; CPIRN-UDI/IPG-Center of Potential and Innovation of Natural Resources, Research Unit for Inland Development (UDI), Polytechnic Institute of Guarda, 6300-559 Guarda, Portugal.; Chemical Process Engineering and Forest Products Research Centre, Department of Chemical Engineering, Pólo II-Pinhal de Marrocos, University of Coimbra, 3030-790 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 27; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Rubus*/chemistry
Morus*
Fruit/chemistry ; Antioxidants/analysis ; Phenols/analysis ; Plant Extracts/chemistry
Czasopismo naukowe
Tytuł:
Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies.
Autorzy:
Saraiva SM; CPIRN-UDI/IPG, Center of Potential and Innovation of Natural Resources, Research Unit for Inland Development (UDI), Polytechnic Institute of Guarda, 6300-559 Guarda, Portugal.
Jacinto TA; CPIRN-UDI/IPG, Center of Potential and Innovation of Natural Resources, Research Unit for Inland Development (UDI), Polytechnic Institute of Guarda, 6300-559 Guarda, Portugal.
Gonçalves AC; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.
Gaspar D; Department of Sport Sciences, University of Beira Interior, 6201-001 Covilhã, Portugal.
Silva LR; CPIRN-UDI/IPG, Center of Potential and Innovation of Natural Resources, Research Unit for Inland Development (UDI), Polytechnic Institute of Guarda, 6300-559 Guarda, Portugal.; CICS-UBI-Health Sciences Research Centre, University of Beira Interior, 6201-001 Covilhã, Portugal.; Department of Chemical Engineering, University of Coimbra, CIEPQPF, Rua Sílvio Lima, Pólo II-Pinhal de Marrocos, 3030-790 Coimbra, Portugal.
Pokaż więcej
Źródło:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Jul 27; Vol. 16 (8). Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Tytuł:
Monocytes in the Characterization of Pain in Palliative Patients with Severe Dementia-A Pilot Study.
Autorzy:
Ribeiro H; Community Support Team in Palliative Care-Group of Health Centers Gaia, 4400-043 Vila Nova de Gaia, Portugal.; Faculty of Medicine, University do Porto, 4200-219 Porto, Portugal.; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, 3004-304 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-304 Coimbra, Portugal.
Alves R; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, 3004-304 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-304 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, University Clinics of Hematology and Oncology, 3004-304 Coimbra, Portugal.
Jorge J; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, 3004-304 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-304 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, University Clinics of Hematology and Oncology, 3004-304 Coimbra, Portugal.
Gonçalves AC; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, 3004-304 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-304 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, University Clinics of Hematology and Oncology, 3004-304 Coimbra, Portugal.
Sarmento-Ribeiro AB; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, 3004-304 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-304 Coimbra, Portugal.; Laboratory of Oncobiology and Hematology (LOH), Faculty of Medicine, University of Coimbra, University Clinics of Hematology and Oncology, 3004-304 Coimbra, Portugal.; Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-075 Coimbra, Portugal.
Teixeira-Veríssimo M; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-075 Coimbra, Portugal.
Andrade JP; , Faculty of Medicine, University of Porto, 4200-219 Porto, Portugal.; Unit of Anatomy, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-219 Porto, Portugal.
Dourado M; Faculty of Medicine, University of Coimbra, 3004-304 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environment Genetics and Oncobiology (CIMAGO), FMUC, 3004-304 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-304 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 27; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 27.
Typ publikacji:
Journal Article
MeSH Terms:
Monocytes*/metabolism
Dementia*/complications
Dementia*/metabolism
Humans ; Pilot Projects ; Antigens, Differentiation, Myelomonocytic/metabolism ; Biomarkers/metabolism ; Membrane Proteins/metabolism ; Pain/metabolism
Czasopismo naukowe
Tytuł:
Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
Autorzy:
Jorge J; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Neves J; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Alves R; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Geraldes C; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-061 Coimbra, Portugal.
Gonçalves AC; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Sarmento-Ribeiro AB; Laboratory of Oncobiology and Hematology (LOH), University Clinic of Hematology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), FMUC, University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-061 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 May 23; Vol. 24 (11). Date of Electronic Publication: 2023 May 23.
Typ publikacji:
Journal Article
MeSH Terms:
Sesquiterpenes*/pharmacology
Lymphoma*/drug therapy
Humans ; NF-kappa B/metabolism ; Reactive Oxygen Species/metabolism ; Cell Line, Tumor ; Apoptosis ; I-kappa B Proteins
Czasopismo naukowe
Tytuł:
Association between Clinical and Histopathological Findings in Intestinal Neuronal Dysplasia Type B: An Advance towards Its Definition as a Disease.
Autorzy:
Gonçalves AC; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
de Faria Oliveira IS; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
Hamamoto Filho PT; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
Ortolan EVP; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
Terra SA; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
Rodrigues MAM; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
de Arruda Lourenção PLT; Botucatu Medical School, São Paulo State University (UNESP), Botucatu 18618-687, Brazil.
Pokaż więcej
Źródło:
Life (Basel, Switzerland) [Life (Basel)] 2023 May 12; Vol. 13 (5). Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Zinc: From Biological Functions to Therapeutic Potential.
Autorzy:
Costa MI; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.
Sarmento-Ribeiro AB; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.; Hematology Service, Centro Hospitalar e Universitário de Coimbra (CHUC), 3000-061 Coimbra, Portugal.
Gonçalves AC; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR)-Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-504 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-061 Coimbra, Portugal.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Mar 02; Vol. 24 (5). Date of Electronic Publication: 2023 Mar 02.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Trace Elements*/metabolism
Physiological Phenomena*
Humans ; Zinc/metabolism ; Homeostasis/physiology ; Carrier Proteins/metabolism
Czasopismo naukowe
Tytuł:
Alvespimycin Inhibits Heat Shock Protein 90 and Overcomes Imatinib Resistance in Chronic Myeloid Leukemia Cell Lines.
Autorzy:
Alves R; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.
Santos D; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.
Jorge J; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.
Gonçalves AC; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.
Catarino S; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.
Girão H; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.
Melo JB; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.; Cytogenetics and Genomics Laboratory, Institute of Cellular and Molecular Biology, Faculty of Medicine (FMUC), 3000-548 Coimbra, Portugal.
Sarmento-Ribeiro AB; Laboratory of Oncobiology and Hematology (LOH), University Clinics of Hematology and Oncology, Group of Environmental Genetics of Oncobiology (CIMAGO), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine (FMUC), University of Coimbra, 3000-548 Coimbra, Portugal.; Center for Innovative Biomedicine and Biotechnology (CIBB), 3004-531 Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), 3000-370 Coimbra, Portugal.; Hematology Service, Centro Hospitalar Universitário de Coimbra (CHUC), 3004-561 Coimbra, Portugal.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2023 Jan 26; Vol. 28 (3). Date of Electronic Publication: 2023 Jan 26.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*/metabolism
Humans ; Apoptosis ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Fusion Proteins, bcr-abl/genetics ; Fusion Proteins, bcr-abl/metabolism ; Heat-Shock Proteins ; Imatinib Mesylate/pharmacology ; Imatinib Mesylate/therapeutic use ; K562 Cells ; HSP90 Heat-Shock Proteins/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies